Michael Landsittel - Net Worth and Insider Trading

Michael Landsittel Net Worth

The estimated net worth of Michael Landsittel is at least $6 Million dollars as of 2024-11-29. Michael Landsittel is the CHIEF FINANCIAL OFFICER of Blueprint Medicines Corp and owns about 67,208 shares of Blueprint Medicines Corp (BPMC) stock worth over $6 Million. Details can be seen in Michael Landsittel's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Landsittel has not made any transactions after 2024-08-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Michael Landsittel

To

Michael Landsittel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Michael Landsittel owns 1 companies in total, including Blueprint Medicines Corp (BPMC) .

Click here to see the complete history of Michael Landsittel’s form 4 insider trades.

Insider Ownership Summary of Michael Landsittel

Ticker Comapny Transaction Date Type of Owner
BPMC Blueprint Medicines Corp 2024-08-15 Principal FAO

Michael Landsittel Latest Holdings Summary

Michael Landsittel currently owns a total of 1 stock. Michael Landsittel owns 67,208 shares of Blueprint Medicines Corp (BPMC) as of August 15, 2024, with a value of $6 Million.

Latest Holdings of Michael Landsittel

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BPMC Blueprint Medicines Corp 2024-08-15 67,208 95.10 6,391,481

Holding Weightings of Michael Landsittel


Michael Landsittel Form 4 Trading Tracker

According to the SEC Form 4 filings, Michael Landsittel has made a total of 8 transactions in Blueprint Medicines Corp (BPMC) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Blueprint Medicines Corp is the sale of 4,409 shares on August 15, 2024, which brought Michael Landsittel around $419,869.

Insider Trading History of Michael Landsittel

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Michael Landsittel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Michael Landsittel Ownership Network

Ownership Network List of Michael Landsittel

No Data

Ownership Network Relation of Michael Landsittel

Insider Network Chart

Michael Landsittel Owned Company Details

What does Blueprint Medicines Corp do?

Who are the key executives at Blueprint Medicines Corp?

Michael Landsittel is the Principal FAO of Blueprint Medicines Corp. Other key executives at Blueprint Medicines Corp include director & CEO & President Jeffrey W. Albers , President & R and D Fouad Namouni , and Chief Commercial Officer Philina Lee .

Blueprint Medicines Corp (BPMC) Insider Trades Summary

Over the past 18 months, Michael Landsittel made 5 insider transaction in Blueprint Medicines Corp (BPMC) with a net sale of 38,146. Other recent insider transactions involving Blueprint Medicines Corp (BPMC) include a net sale of 170,808 shares made by Jeffrey W. Albers , a net sale of 14,415 shares made by Ariel Hurley , and a net sale of 9,342 shares made by Christopher K. Murray .

In summary, during the past 3 months, insiders sold 48,159 shares of Blueprint Medicines Corp (BPMC) in total and bought 0 shares, with a net sale of 48,159 shares. During the past 18 months, 489,690 shares of Blueprint Medicines Corp (BPMC) were sold and 0 shares were bought by its insiders, resulting in a net sale of 489,690 shares.

Blueprint Medicines Corp (BPMC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Blueprint Medicines Corp Insider Transactions

No Available Data

Michael Landsittel Mailing Address

Above is the net worth, insider trading, and ownership report for Michael Landsittel. You might contact Michael Landsittel via mailing address: Blueprint Medicines Corp., 214 First Street, Suite 340/350, Cambridge Ma 02142.

Discussions on Michael Landsittel

No discussions yet.